Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
IHK | Ann: Removal from Official Quotation | 22/06/18 | 0 | 859 | |||
|
|||||||
IHK | Ann: Net Tangible Asset Backing | 21/06/18 | 0 | 591 | |||
|
|||||||
IHK | Ann: Distribution | 19/06/18 | 0 | 626 | |||
|
|||||||
IHK | Ann: Suspension from Offical Quotation - Various ETFs | 15/06/18 | 0 | 614 | |||
|
|||||||
IHK | Ann: Net Tangible Asset Backing | 14/06/18 | 0 | 534 | |||
|
|||||||
IHK | Ann: Distribution Dates | 12/06/18 | 0 | 615 | |||
|
|||||||
IHK | Ann: Number of Outstanding iShares Units | 07/06/18 | 0 | 498 | |||
|
|||||||
IHK | Ann: Net Tangible Asset Backing | 07/06/18 | 0 | 451 | |||
|
See All Discussions